Furthermore, we determined that knockdown of AGAP2-AS1-mediated tumor-suppressive effects on NSCLC cells are partly dependent on regulation of LATS2 and KLF2 expression. The gene discussed is KLF2; the disease is non-small cell lung carcinoma.